88 related articles for article (PubMed ID: 2881039)
1. Herpes-virus immunity and acute graft-versus-host disease.
Gratama JW; Zwaan FE; Stijnen T; Weijers TF; Weiland HT; D'Amaro J; Hekker AC; The TH; de Gast GC; Vossen JM
Lancet; 1987 Feb; 1(8531):471-4. PubMed ID: 2881039
[TBL] [Abstract][Full Text] [Related]
2. Pretransplant herpes virus serology and chronic graft-versus-host disease.
Boström L; Ringdén O; Sundberg B; Ljungman P; Linde A; Nilsson B
Bone Marrow Transplant; 1989 Sep; 4(5):547-52. PubMed ID: 2551436
[TBL] [Abstract][Full Text] [Related]
3. Pretransplant herpesvirus serology and acute graft-versus-host disease.
Boström L; Ringdén O; Sundberg B; Linde A; Tollemar J; Nilsson B
Transplantation; 1988 Oct; 46(4):548-52. PubMed ID: 2845612
[TBL] [Abstract][Full Text] [Related]
4. Marrow donor immunity to herpes simplex virus: association with acute graft-versus-host disease.
Gratama JW; Sinnige LG; Weijers TF; Zwaan FE; van Heugten JG; Stijnen T; D'Amaro J; The TH; Hekker AC; de Gast GC
Exp Hematol; 1987 Aug; 15(7):735-40. PubMed ID: 3038583
[TBL] [Abstract][Full Text] [Related]
5. Intensification of GVHD prophylaxis interferes with the effects of pretransplant herpes virus serology on the occurrence of grades II-IV acute graft-versus-host disease.
Gratama JW; vd Nat H; Weiland HT; Stijnen T; Fibbe WE; Vossen JM; Willemze R; Verdonck LF
Ann Hematol; 1992 Jun; 64 Suppl():A137-9. PubMed ID: 1322184
[TBL] [Abstract][Full Text] [Related]
6. A role of herpes virus serology for the development of acute graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation.
Boström L; Ringdén O; Gratama JW; Jacobsen N; Prentice HG; Zwaan FE; Nilsson B
Bone Marrow Transplant; 1990 May; 5(5):321-6. PubMed ID: 2190659
[TBL] [Abstract][Full Text] [Related]
7. Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients.
Gratama JW; Oosterveer MA; Lepoutre JM; van Rood JJ; Zwaan FE; Vossen JM; Kapsenberg JG; Richel D; Klein G; Ernberg I
Transplantation; 1990 Apr; 49(4):725-30. PubMed ID: 2158159
[TBL] [Abstract][Full Text] [Related]
8. Impact of Donor Epstein-Barr Virus Serostatus on the Incidence of Graft-Versus-Host Disease in Patients With Acute Leukemia After Hematopoietic Stem-Cell Transplantation: A Study From the Acute Leukemia and Infectious Diseases Working Parties of the European Society for Blood and Marrow Transplantation.
Styczynski J; Tridello G; Gil L; Ljungman P; Hoek J; Iacobelli S; Ward KN; Cordonnier C; Einsele H; Socie G; Milpied N; Veelken H; Chevallier P; Yakoub-Agha I; Maertens J; Blaise D; Cornelissen J; Michallet M; Daguindau E; Petersen E; Passweg J; Greinix H; Duarte RF; Kröger N; Dreger P; Mohty M; Nagler A; Cesaro S
J Clin Oncol; 2016 Jul; 34(19):2212-20. PubMed ID: 27091716
[TBL] [Abstract][Full Text] [Related]
9. Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease.
Boström L; Ringdén O; Forsgren M
Scand J Immunol; 1991 Jul; 34(1):45-52. PubMed ID: 1648786
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for acute graft-versus-host disease in 291 consecutive HLA-identical bone marrow transplant recipients.
Hägglund H; Boström L; Remberger M; Ljungman P; Nilsson B; Ringdén O
Bone Marrow Transplant; 1995 Dec; 16(6):747-53. PubMed ID: 8750264
[TBL] [Abstract][Full Text] [Related]
11. Correlation of pretransplant viral serology and complications of bone marrow transplantation.
Ringdén O
Ann Hematol; 1992 Jun; 64 Suppl():A143-7. PubMed ID: 1322186
[TBL] [Abstract][Full Text] [Related]
12. A European multicenter study of chronic graft-versus-host disease. The role of cytomegalovirus serology in recipients and donors--acute graft-versus-host disease, and splenectomy.
Boström L; Ringdén O; Jacobsen N; Zwaan F; Nilsson B
Transplantation; 1990 Jun; 49(6):1100-5. PubMed ID: 2193443
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
Carlens S; Ringdén O; Remberger M; Lönnqvist B; Hägglund H; Klaesson S; Mattsson J; Svahn BM; Winiarski J; Ljungman P; Aschan J
Bone Marrow Transplant; 1998 Oct; 22(8):755-61. PubMed ID: 9827972
[TBL] [Abstract][Full Text] [Related]
14. Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis.
Qayed M; Wang T; Hemmer MT; Spellman S; Arora M; Couriel D; Alousi A; Pidala J; Abdel-Azim H; Aljurf M; Ayas M; Bitan M; Cairo M; Choi SW; Dandoy C; Delgado D; Gale RP; Hale G; Frangoul H; Kamble RT; Kharfan-Dabaja M; Lehman L; Levine J; MacMillan M; Marks DI; Nishihori T; Olsson RF; Hematti P; Ringden O; Saad A; Satwani P; Savani BN; Schultz KR; Seo S; Shenoy S; Waller EK; Yu L; Horowitz MM; Horan J
Biol Blood Marrow Transplant; 2018 Mar; 24(3):521-528. PubMed ID: 29155316
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of pretransplant donor anti-recipient cytotoxic and helper T lymphocyte responses as correlates of acute graft-vs.-host disease and survival after unrelated marrow transplantation.
Pei J; Martin PJ; Longton G; Masewicz S; Mickelson E; Petersdorf E; Anasetti C; Hansen J
Biol Blood Marrow Transplant; 1997 Aug; 3(3):142-9. PubMed ID: 9310191
[TBL] [Abstract][Full Text] [Related]
16. Lymphoproliferative response to herpes simplex virus type 1, cytomegalovirus, Epstein-Barr virus, varicella zoster virus, human herpes virus 6, 7, and 8 antigen stimulation in pediatric allogeneic stem cell transplant recipients.
Cheng FW; Chan PK; Lee V; Leung WK; Shing MK; Li CK; Leung TF
Pediatr Transplant; 2010 Sep; 14(6):761-9. PubMed ID: 20534025
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Rocha V; Wagner JE; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM; Gluckman E
N Engl J Med; 2000 Jun; 342(25):1846-54. PubMed ID: 10861319
[TBL] [Abstract][Full Text] [Related]
18. Donor alloreactivity may predict acute graft-versus-host disease in patients receiving marrow transplants from HLA identical siblings.
Johnsen HE; Mickelson E; Beatty PG; Hansen JA
Bone Marrow Transplant; 1992 Feb; 9(2):91-6. PubMed ID: 1533334
[TBL] [Abstract][Full Text] [Related]
19. The impact of pretransplant herpesvirus serology on acute and chronic graft-versus-host disease. Leukaemia Working Party of the European Group for Bone Marrow Transplantation.
Boström L; Ringdén O; Gratama JW; Jacobsen N; Zwaan F; Nilsson B
Transplant Proc; 1990 Feb; 22(1):206-7. PubMed ID: 2155486
[No Abstract] [Full Text] [Related]
20. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
Keever-Taylor CA; Passweg J; Kawanishi Y; Casper J; Flomenberg N; Baxter-Lowe LA
Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
